These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28076449)
21. SAMe-TT2R2 Score in the Outpatient Anticoagulation Clinic to Predict Time in Therapeutic Range and Adverse Events. Pivatto Junior F; Scheffel RS; Ries L; Wolkind RR; Marobin R; Barkan SS; Amon LC; Biolo A Arq Bras Cardiol; 2017 Apr; 108(4):290-296. PubMed ID: 28538758 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular Risk Stratification and Statin Eligibility Based on the Brazilian vs. North American Guidelines on Blood Cholesterol Management. Cesena FHY; Laurinavicius AG; Valente VA; Conceição RD; Santos RD; Bittencourt MS Arq Bras Cardiol; 2017 Jun; 108(6):508-517. PubMed ID: 28699974 [TBL] [Abstract][Full Text] [Related]
23. Analysis of the Revised Trauma Score (RTS) in 200 victims of different trauma mechanisms. Alvarez BD; Razente DM; Lacerda DA; Lother NS; VON-Bahten LC; Stahlschmidt CM Rev Col Bras Cir; 2016; 43(5):334-340. PubMed ID: 27982326 [TBL] [Abstract][Full Text] [Related]
24. Judicial demand of medications through the Federal Justice of the State of Paraná. Nisihara RM; Possebom AC; Borges LMC; Shwetz ACA; Bettes FFB Einstein (Sao Paulo); 2017; 15(1):85-91. PubMed ID: 28444095 [TBL] [Abstract][Full Text] [Related]
25. Spatial distribution of tuberculosis in a municipality in the interior of São Paulo, 2008-2013. Fusco APB; Arcêncio RA; Yamamura M; Palha PF; Reis AAD; Alecrim TFA; Protti ST Rev Lat Am Enfermagem; 2017 Jun; 25():e2888. PubMed ID: 28591296 [TBL] [Abstract][Full Text] [Related]
26. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Serruys PW; Chevalier B; Dudek D; Cequier A; Carrié D; Iniguez A; Dominici M; van der Schaaf RJ; Haude M; Wasungu L; Veldhof S; Peng L; Staehr P; Grundeken MJ; Ishibashi Y; Garcia-Garcia HM; Onuma Y Lancet; 2015 Jan; 385(9962):43-54. PubMed ID: 25230593 [TBL] [Abstract][Full Text] [Related]
27. In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study. Lago IM; Novaes GC; Badran AV; Pavão RB; Barbosa R; Figueiredo GL; Lima MO; Haddad JL; Schmidt A; Marin JA Arq Bras Cardiol; 2016 Nov; 107(5):403-410. PubMed ID: 27982267 [TBL] [Abstract][Full Text] [Related]
28. Utility of Ultraportable Echocardiography in the Preoperative Evaluation of Noncardiac Surgery. Costa JA; Almeida ML; Estrada TC; Werneck GL; Rocha AM; Rosa ML; Ribeiro ML; Mesquita CT Arq Bras Cardiol; 2016 Nov; 107(5):420-426. PubMed ID: 27982268 [TBL] [Abstract][Full Text] [Related]
29. Anatomic pulmonary resection via video-assisted thoracic surgery: analysis of 117 cases at a referral center in Brazil. Soder SA; Barth F; Perin FA; Felicetti JC; Camargo JJP; Camargo SM J Bras Pneumol; 2017; 43(2):129-133. PubMed ID: 28538780 [TBL] [Abstract][Full Text] [Related]
30. Hard metal lung disease: a case series. Mizutani RF; Terra-Filho M; Lima E; Freitas CS; Chate RC; Kairalla RA; Carvalho-Oliveira R; Santos UP J Bras Pneumol; 2016; 42(6):447-452. PubMed ID: 28117477 [TBL] [Abstract][Full Text] [Related]
32. Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study. Berton DC; Santos ÁH; Bohn I; Lima RQ; Breda V; Teixeira PJ J Bras Pneumol; 2016; 42(5):367-373. PubMed ID: 27812637 [TBL] [Abstract][Full Text] [Related]
33. Food consumed outside the home in Brazil according to places of purchase. Bezerra IN; Moreira TM; Cavalcante JB; Souza AM; Sichieri R Rev Saude Publica; 2017 Mar; 51(0):15. PubMed ID: 28355339 [TBL] [Abstract][Full Text] [Related]
34. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961 [TBL] [Abstract][Full Text] [Related]
35. Systemic Arterial Hypertension in Patients Exposed to Cesium-137 in Goiânia-GO: Prevalence Study. Rodrigues JVR; Pinto MM; Figueredo RMP; Lima H; Souto R; Sacchetim SC Arq Bras Cardiol; 2017; 108(6):533-538. PubMed ID: 28562830 [TBL] [Abstract][Full Text] [Related]
36. Living arrangements of the elderly and the sociodemographic and health determinants: a longitudinal study. Bolina AF; Tavares DM Rev Lat Am Enfermagem; 2016 Aug; 24():e2737. PubMed ID: 27508909 [TBL] [Abstract][Full Text] [Related]
37. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction). Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924 [TBL] [Abstract][Full Text] [Related]